GlassScriptPhysician profile
David Channing Carter
NPI 1447414255
$1,618.42
in general payments reported to CMS, 2019-2025
16 companies · $330 in 2025
The $330 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $209 · 2021: $97.86 · 2022: $336 · 2023: $307 · 2024: $130 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $301.58 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Glaxosmithkline, LLC. | $289.72 | 2019-2025 | Bexsero |
| Sanofi Pasteur INC. | $197.09 | 2019-2025 | |
| Pfizer INC. | $190.75 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $120.12 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $107.28 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $86.80 | 2019-2022 | |
| Corium, LLC | $71.32 | 2022-2023 | Azstarys |
| Ultragenyx Pharmaceutical INC. | $60.23 | 2020-2022 | |
| Seqirus USA INC | $49.63 | 2022-2023 | Flucelvax Quadrivalent |
| Sobi, INC | $47.95 | 2022-2023 | |
| Kaleo, INC. | $35.34 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $17.67 | 2022 | |
| Tris Pharma INC | $15.04 | 2021 | |
| Supernus Pharmaceuticals, INC. | $14.76 | 2025 | Qelbree |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.